SurvivorNet on MSN
ASCO 2026: A major prostate cancer trial shows drug can keep high-risk disease from returning for longer
Data from the PROTEUS trial showed that adding a hormone-blocking pill called apalutamide to standard hormone therapy, both ...
By doing hormone therapy up front in prostate cancer cases, the hope was to shrink the relapse rate after surgery. Results ...
By Sneha S K May 31 (Reuters) - Johnson & Johnson's prostate cancer drug Erleada used with hormone-blocking therapy six ...
Radical prostatectomy is potentially curative in patients with high-risk localized or locally advanced prostate cancer; however, relapse occurs within 5 years in up to 50% of patients. We ...
MedPage Today on MSN
Practice-Changing Trial in Prostate Cancer Shows Benefits of Perioperative Therapy
ADT plus apalutamide before and after surgery significantly improved metastasis-free survi ...
Research found that the weight-loss medications may reduce the spread of several obesity-related cancers, including lung, ...
Only men with a dangerous genetic variant and a family history of cancer should be offered screening, say UK advisors.
A Chinese surgeon remotely operated a robotic system to remove a prostate tumor from a patient 220 kilometers away. Utilizing ...
A whole-food plant-based diet can significantly increase weight loss for men with prostate cancer and overweight or obesity ...
In her forthcoming memoir, former First Lady Jill Biden candidly addresses former President Joe Biden's stage IV prostate ...
Cebu Daily News on MSN
Early-stage prostate cancer patients eligible for P100K subsidy
MANILA, Philippines – Filipino men can ease their financial worries if diagnosed with early-stage prostate cancer through a ...
Johnson & Johnson's Erleada drug, combined with hormone therapy, significantly reduces the risk of prostate cancer spread and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results